Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Name: Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Published: 2026
License: Public Domain

Immuneering Corporation · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

pancreatic-cancer pancreatic-ductal-adenocarcinoma

pancreatic cancer, pancreatic cancer metastatic, pdac, pdac - pancreatic ductal adenocarcinoma, pancreatic ductal adenocarcinoma, pancreatic adenocarcinoma metastatic, pancreatic ductal adenocarcinoma (pdac), pancreatic adenocarcinoma, mitogen-activated protein kinase (mapk), mapk, mek, metastatic cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 874128
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.